Initial structure-activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles

被引：50
|
作者：
Chu, L
Hutchins, JE
Weber, AE
Lo, JL
Yang, YT
Cheng, K
Smith, RG
Fisher, MH
Wyvratt, MJ
Goulet, MT
机构：
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Biochem & Physiol, Rahway, NJ 07065 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 04期
关键词：
D O I：
10.1016/S0960-894X(00)00707-1
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A nonpeptidyl GnRH receptor antagonist (1), with a unique 2-arylindole core, was identified through the Merck inhouse screening for binding affinity on the rat GnRH receptor. SAR studies directed toward the alkoxy-ethanolamine and 2-aryl groups resulted in a simpler lead structure with improved activity. This compound 50 exhibits a 60-fold improvement in binding activity over our initial lead 1. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：509 / 513
页数：5
相关论文
共 50 条
  • [31] A novel synthesis of 2-arylpyrrolo[1,2-a]pyrimid-7-ones and their structure-activity relationships as potent GnRH receptor antagonists
    Zhu, YF
    Wilcoxen, K
    Saunders, J
    Guo, ZQ
    Gao, YH
    Connors, PJ
    Gross, TD
    Tucci, FC
    Struthers, RS
    Reinhart, GJ
    Xie, Q
    Chen, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (03) : 403 - 406
  • [32] Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor
    Nozawa, Dai
    Okubo, Taketoshi
    Ishii, Takaaki
    Kakinuma, Hiroyuki
    Chaki, Shigeyuki
    Okuyama, Shigeru
    Nakazato, Atsuro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (05) : 1989 - 2005
  • [33] STRUCTURE-ACTIVITY STUDY OF NEUROKININS - ANTAGONISTS FOR THE NEUROKININ-2 RECEPTOR
    DION, S
    ROUISSI, N
    NANTEL, F
    JUKIC, D
    RHALEB, NE
    TOUSIGNANT, C
    TELEMAQUE, S
    DRAPEAU, G
    REGOLI, D
    NALINE, E
    ADVENIER, C
    ROVERO, P
    MAGGI, CA
    PHARMACOLOGY, 1990, 41 (04) : 184 - 194
  • [34] BENZODIAZEPINES - RECEPTOR AND STRUCTURE-ACTIVITY RELATIONSHIP
    DASILVEIRA, MAB
    REVISTA BRASILEIRA DE MEDICINA, 1988, 45 (05) : 176 - 178
  • [35] Structure-activity relationship studies of group I metabotropic glutamate receptor antagonists.
    VanWagenen, BC
    Artman, LD
    Balandrin, MF
    Barkdull, LT
    Fairbanks, DM
    Hammerland, LG
    Heaton, WL
    Hung, BCP
    Jacobson, P
    Krapcho, KJ
    Levinthal, C
    Lloyd, N
    Logan, MA
    Moe, ST
    Mueller, A
    Sheehan, SMK
    Smith, DL
    Storjohann, L
    Stormann, TM
    Trovato, R
    Walton, RJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A114 - A114
  • [36] MEDI 72-Design, synthesis and structure-activity relationship of novel CCR2 antagonists
    Kothandaraman, Shankaran
    Donnely, Karla L.
    Jiao, Richard X.
    Butora, Gabor
    Pasternak, Alexander
    Morriello, Gregori J.
    Goble, Steve
    Zhou, Changyou
    Yang, Lihu
    Mills, Sander G.
    MacCoss, Malcolm
    Ayala, Julia M.
    Vicario, Pasquale P.
    Cascieri, Margaret A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [37] Chemistry of ginkgolides: structure-activity relationship as PAF antagonists
    Hu, LH
    Chen, ZL
    Cheng, XF
    Xie, YY
    PURE AND APPLIED CHEMISTRY, 1999, 71 (06) : 1153 - 1156
  • [38] Chemistry, design, and structure-activity relationship of cocaine antagonists
    Singh, S
    CHEMICAL REVIEWS, 2000, 100 (03) : 925 - 1024
  • [39] Structure-activity relationship analysis of 3-phenylpyrazole derivatives as androgen receptor antagonists
    Han, Wenya
    Li, Jiazhong
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (09): : 2582 - 2591
  • [40] Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship
    Figuerola-Asencio, Laura
    Morales, Paula
    Zhao, Pingwei
    Hurst, Dow P.
    Sayed, Sommayah S.
    Colon, Katsuya L.
    Gomez-Canas, Maria
    Fernandez-Ruiz, Javier
    Croatt, Mitchell P.
    Reggio, Patricia H.
    Abood, Mary E.
    Jagerovic, Nadine
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (01): : 18 - 25
12345